https://tgx-221inhibitor.com/y....our-small-deflection
Through the information of 48 treatment-naïve nAMD eyes that received intravitreal ranibizumab pro re nata for up to one year, we used the aqueous humour concentrations of C-X-C motif chemokine ligand 1 (CXCL1), CXCL12, CXCL13, interferon-γ-induced protein 10, monocyte chemoattractant necessary protein 1 (MCP-1), C-C theme chemokine ligand 11, interleukin 6 (IL-6), IL-10, and matrix metalloproteinase 9 (MMP-9). After stepwise regression, multiva
Like
Comment
Share
